Logo image of CANX.CA

CANEX METALS INC (CANX.CA) Stock Fundamental Analysis

TSX-V:CANX - TSX Venture Exchange - CA13751X1015 - Common Stock - Currency: CAD

0.07  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CANX. CANX was compared to 797 industry peers in the Metals & Mining industry. While CANX has a great health rating, there are worries on its profitability. CANX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CANX has reported negative net income.
CANX had a negative operating cash flow in the past year.
CANX had negative earnings in each of the past 5 years.
In the past 5 years CANX always reported negative operating cash flow.
CANX.CA Yearly Net Income VS EBIT VS OCF VS FCFCANX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2022 2023 2024 0 -500K -1M -1.5M -2M -2.5M

1.2 Ratios

CANX's Return On Assets of -5.91% is fine compared to the rest of the industry. CANX outperforms 68.51% of its industry peers.
CANX has a better Return On Equity (-6.03%) than 71.39% of its industry peers.
Industry RankSector Rank
ROA -5.91%
ROE -6.03%
ROIC N/A
ROA(3y)-9.09%
ROA(5y)N/A
ROE(3y)-9.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CANX.CA Yearly ROA, ROE, ROICCANX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2022 2023 2024 0 10 -10 -20

1.3 Margins

CANX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CANX.CA Yearly Profit, Operating, Gross MarginsCANX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2022 2023 2024

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, CANX has more shares outstanding
The number of shares outstanding for CANX has been increased compared to 5 years ago.
CANX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CANX.CA Yearly Shares OutstandingCANX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2022 2023 2024 20M 40M 60M 80M 100M
CANX.CA Yearly Total Debt VS Total AssetsCANX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

An Altman-Z score of 43.07 indicates that CANX is not in any danger for bankruptcy at the moment.
CANX has a Altman-Z score of 43.07. This is amongst the best in the industry. CANX outperforms 86.20% of its industry peers.
CANX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 43.07
ROIC/WACCN/A
WACCN/A
CANX.CA Yearly LT Debt VS Equity VS FCFCANX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

A Current Ratio of 5.46 indicates that CANX has no problem at all paying its short term obligations.
CANX has a better Current ratio (5.46) than 76.54% of its industry peers.
CANX has a Quick Ratio of 5.46. This indicates that CANX is financially healthy and has no problem in meeting its short term obligations.
CANX's Quick ratio of 5.46 is fine compared to the rest of the industry. CANX outperforms 76.79% of its industry peers.
Industry RankSector Rank
Current Ratio 5.46
Quick Ratio 5.46
CANX.CA Yearly Current Assets VS Current LiabilitesCANX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2022 2023 2024 500K 1M 1.5M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.89% over the past year.
EPS 1Y (TTM)28.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CANX.CA Price Earnings VS Forward Price EarningsCANX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CANX.CA Per share dataCANX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02 0.03 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CANX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CANEX METALS INC

TSX-V:CANX (8/1/2025, 7:00:00 PM)

0.07

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-24 2025-07-24
Earnings (Next)12-11 2025-12-11
Inst Owners2.64%
Inst Owner ChangeN/A
Ins Owners8.36%
Ins Owner ChangeN/A
Market Cap10.26M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.67
P/tB 1.67
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.91%
ROE -6.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-9.09%
ROA(5y)N/A
ROE(3y)-9.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.46
Quick Ratio 5.46
Altman-Z 43.07
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y55.57%
OCF growth 3YN/A
OCF growth 5YN/A